Barclays’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

Barclays’s Portfolio ARMO Stock Details ARMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,416	Closed	-$53K	–	7556
2018 Q1	$53K	Buy	+1,416	New	+$59.5K	﹤0.01%	5869

Barclays's ARMO Position: Q2 2018 in Review

Barclays sold out of ARMO BioSciences, Inc. Common Stock (ARMO) in Q2 2018, closing a stake of 1,416 shares — an estimated $53K sold.

Barclays first reported a position in ARMO in Q1 2018 and held it in 1 quarter. The position peaked at $53K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARMO as of Q2 2018.

Barclays reported no remaining ARMO BioSciences, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Barclays sold 1,416 ARMO BioSciences, Inc. Common Stock shares in Q2 2018, an estimated $53K.
Barclays first reported a position in ARMO BioSciences, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
Barclays's ARMO BioSciences, Inc. Common Stock position peaked at $53K in Q1 2018.
0 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q2 2018.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.